Skip to main content
. 2021 Nov 25;7(2):232–240. doi: 10.1016/j.ekir.2021.11.013

Table 2.

Major bleeding complications of patients with and without diabetes

Event Total patients (N = 76,302) Patients without diabetes (n = 68,057) Patients with diabetes (n = 8245) P value
Major bleeding complications, n (%) 678 (0.9) 424 (0.6) 254 (3.1) <0.001
 RBC transfusion, n (%) 622 (0.8) 381 (0.6) 241 (2.9) <0.001
 Invasive hemostasis, n (%) 109 (0.1) 82 (0.1) 27 (0.3) <0.001
 Massive RBC transfusion, n (%) 201 (0.3) 70 (0.1) 131 (1.6) <0.001

RBC, red blood cell.

Some patients received both RBC transfusion and invasive hemostasis. Thus, they were not mutually exclusive.